Resection and Transcatheter Arterial Chemoembolization for Small Hepatocellular Carcinoma close to great vessels: a Prospective Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000619

Enrollment

Unknown

Registered

2009-12-23

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

A:Resection

B:Transcatheter arterial chemoembolization (TACE)

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis is "hepatocellular carcinoma(HCC)"; 2. Single nodule<=3cm without macrovascular tumor embolus or extrahepatic metastasis; 3. Liver function is Child-Pugh A or B; 4. Tumor is closed to great vessels(vena cava after liver, main branches of portal vein or trunk of hepatic vein)according to imageology (CT or MRI); 5. Patients that do not receive any other anti-tumor therapy previously.

Exclusion criteria

Exclusion criteria: 1. Patients that refuse to participat in the trial; 2. Patients that can not be followed-up regularly; 3. Patients that have server damage of the heart, lung or kidney function.

Design outcomes

Primary

Measure	Time frame
1-,3-,5-year over-all survival and disease-free survival;	—

Secondary

Measure	Time frame
Operation mortality and incidence rate of complications;	—

Countries

China

Contacts

Public ContactJing Li

li_5hao@hotmail.com+86 21 81875503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026